Innovations in ILD Treatment at ACR 2024

This chapter discusses groundbreaking research on treatments for interstitial lung disease in rheumatoid arthritis patients, focusing on therapies like abatacept and baricitinib. It also covers the prevalence of ILD, comparative treatment analyses for related conditions, and the significance of personalized therapy choices.